Cabozantinib in Brain Metastases From Renal Cell Carcinoma Cabozantinib in Brain Metastases From Renal Cell Carcinoma

Is cabozantinib, a tyrosine kinase inhibitor recently approved for the treatment of metastatic renal cell carcinoma, effective for brain metastases which have been resistant to radiation?Journal of Medical Case Reports
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news